﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Diagnosis of acute myocardial infarction: highlighting cardiac troponins as vital biomarkers</ArticleTitle>
    <FirstPage>85</FirstPage>
    <LastPage>88</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2023.22023</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Pourali</LastName>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Omidi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0067-2475</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2023.22023</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
    </History>
    <Abstract>The molecular marker, cardiac troponin (cTn) is a complex protein that is attached to tropomyosin on the actin filament. It is an essential biomolecule in terms of the calcium-mediated regulation of the contractile apparatus in myofibrils, the release of which is an indication of the dysfunction of cardiomyocytes and hence the initiation of ischemic phenomena in the heart tissue. Fast and accurate analysis of cTn may help the diagnosis and management of acute myocardial infarction (AMI), for which electrochemical biosensors and microfluidics devices can be of great benefit. This editorial aims to highlight the importance of cTn as vital biomarkers in AMI diagnosis.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Acute myocardial infarction</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Biosensor</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cardiac troponin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cardiomyocytes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Electrochemical analysis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Microfluidics</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>